Effects Of Turkish Coffee Consumption On Cardiovascular Markers And Sleep In Healthy Women (NCT07133373) | Clinical Trial Compass
CompletedNot Applicable
Effects Of Turkish Coffee Consumption On Cardiovascular Markers And Sleep In Healthy Women
Jordan40 participantsStarted 2024-08-01
Plain-language summary
This randomized controlled trial aims to evaluate the short-term effects of daily unfiltered Turkish coffee consumption on cardiovascular parameters, appetite-regulating hormones, glucose metabolism, inflammatory markers, and sleep quality in healthy young women. Forty participants will be randomly assigned to an intervention group, consuming standardized servings of Turkish coffee for four weeks, or to a control group abstaining from coffee during the same period. Measurements will be taken at baseline and after the intervention, including blood pressure, lipid profile, leptin, ghrelin, glucose metabolism markers, inflammatory biomarkers, body composition, and sleep quality indices.
Who can participate
Age range
18 Years – 35 Years
Sex
FEMALE
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
Healthy female participants aged between 18 and 35 years
Body Mass Index (BMI) between 18.5 and 29.9 kg/m²
Habitual coffee consumers (1-2 cups/day)
Not on a weight-loss or special medical diet
Not taking medications or supplements that affect sleep, appetite, metabolism, or cardiovascular function
Non-smokers and not using recreational drugs
Willing to comply with study protocol and attend all assessments
Exclusion Criteria:
Pregnancy or lactation
Diagnosed chronic diseases (e.g., diabetes, hypertension, cardiovascular disease)
Known sleep disorders or psychological conditions
Allergy or sensitivity to coffee or caffeine
Irregular menstrual cycle or hormonal disorders
Shift workers or frequent travelers across time zones
Participation in other clinical trials within the past 3 months
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
Change in systolic and diastolic blood pressure after 4 weeks of Turkish coffee consumption